Differences in management of atrial fibrillation between cardiologists and non-cardiologists in Greece

Hellenic Journal of Cardiology

Volumn 51, Issue 2, 2010, Pages 113-121

  Vassilikos, Vassilios P ^a   Mantziari, Aggeliki ^a   Goudis, Christos A ^a   Paraskevaidis, Stelios ^a   Dakos, Georgios ^a   Giannakoulas, Georgios ^a   Giannoglou, Georgios ^a   Mochlas, Sotirios ^a   Styliadis, Ioannis H ^a   Parcharidis, Georgios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Patterns; Practice; Prevention; Stroke; Survey study

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGITALIS; DILTIAZEM; IBUTILIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

ADULT; AGED; ARTICLE; CARDIOLOGIST; CARDIOVERSION; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; DRUG UTILIZATION; EMERGENCY WARD; GENERAL PRACTITIONER; GREECE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; MULTICENTER STUDY; NON CARDIOLOGIST; PAROXYSMAL HEART ATRIUM FIBRILLATION; PHYSICIAN; PRESCRIPTION; QUESTIONNAIRE; RESIDENT; RISK; RISK FACTOR; TREATMENT OUTCOME; TREND STUDY;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOLOGY; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; EXERCISE TEST; FAMILY PRACTICE; GREECE; HUMANS; INTERNAL MEDICINE; LENGTH OF STAY;

EID: 77950831781     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995; 155: 469-473.
2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285: 2370-2375.
3. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983; 106: 389-396. (Pubitemid 13028244)
4. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98: 476-484.
5. Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006; 8: 651-745. (Pubitemid 44472247)
6. Naccarelli GV, Wolbrette DL, Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol. 2003; 91: 15D-26D. (Pubitemid 36372060)
7. Nieuwlaat R, Capucci A, Camm AJ, et al; European Heart Survey Investigators. Atrial fibrillation management: a prospective survey in ESC Member Countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2005; 26: 2422-2434
8. Grönefeld G, Hohnloser SH. Towards a consensus in rate versus rhythm control for management of atrial fibrillation: insights from the PIAF trial. Card Electrophysiol Rev. 2003; 7: 113-117. (Pubitemid 37547900)
9. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet. 2000; 356: 1789-1794.
10. Opolski G, Torbicki A, Kosior DA, et al. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest. 2004; 126: 476-486. (Pubitemid 39093433)
11. Gattellari M, Worthington JM, Zwar NA, Middleton S. The management of non-valvular atrial fibrillation (NVAF) in Australian general practice: bridging the evidence-practice gap. A national, representative postal survey. BMC Fam Pract. 2008; 9: 62.
12. Nabauer M, Gerth A, Limbourg T et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace. 2009; 11: 423-434.
13. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004; 109: 1509-1513. (Pubitemid 38420179)
14. Falk RH. Is rate control or rhythm control preferable in patients with atrial fibrillation? Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation. Circulation. 2005; 111: 3141-3150.
15. Hagens VE, Ranchor AV, Van Sonderen E, et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol. 2004; 43: 241-247. (Pubitemid 38201151)
16. Rienstra M, Van Gelder IC. Who, when and how to rate control for atrial fibrillation. Curr Opin Cardiol. 2008; 23: 23-27. (Pubitemid 351339792)
17. Efremidis M, Sideris A, Xydonas S, et al. Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling. Hellenic J Cardiol. 2008; 49: 19-25. (Pubitemid 351499657)
18. Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol. 1991; 17: 66-72.
19. Connolly SJ, Pogue J, Hart RG, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009; 360: 2066-2078.
20. Anninos H, Andrikopoulos G, Pastromas S, Sakellariou D, Theodorakis G, Vardas P. Triflusal: an old drug in modern antiplatelet therapy. Review of its action, use, safety and effectiveness. Hellenic J Cardiol. 2009; 50: 199-207.
21. Lip GY, Zarifis J, Watson RD, Beevers DG. Physician variation in the management of patients with atrial fibrillation. Heart. 1996; 75: 200-205. (Pubitemid 26068699)
22. Dinh T, Nieuwlaat R, Tieleman RG, et al. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands -The EXAMINE-AF study. A questionnaire survey. Int J Clin Pract. 2007; 61: 24-31. (Pubitemid 46269346)
23. Meiltz A, Zimmermann M, Urban P, Bloch A. Atrial fibril- lation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace. 2008; 10: 674-680. (Pubitemid 351775267)
24. Nieuwlaat R, Olsson SB, Lip GYH, et al. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J. 2007; 153: 1006-1012.
25. Zehnder BS, Schaer BA, Jeker U, Cron TA, Osswald S. Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines. Swiss Med Wkly. 2006; 136: 757-760. (Pubitemid 46121627)
26. Gattellari M, Worthington J, Zwar N, Middleton S. Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians. Stroke. 2008; 39: 227-230.